Scribd Logo
Upload

Welcome to Scribd!

  • Joi210083supp5 Prod 1630095299.72589

    Uploaded by

    Jonas
    10 views1 page
    Anonymized data from a study comparing intravenous fluid treatment with a balanced solution versus 0.9% saline on mortality in critically ill patients will be available beginning January 31, 2022 upon reasonable request. The request must include a short study protocol and be evaluated by the steering committee, with additional approval required from Brazilian regulatory agencies. Supporting documents such as statistical code and consent forms can also be requested from fzampieri@hcor.com.br.

    Original Description:

    Original Title

    joi210083supp5_prod_1630095299.72589

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Anonymized data from a study comparing intravenous fluid treatment with a balanced solution versus 0.9% saline on mortality in critically ill patients will be available beginning January 31, 2022 upon reasonable request. The request must include a short study protocol and be evaluated by the steering committee, with additional approval required from Brazilian regulatory agencies. Supporting documents such as statistical code and consent forms can also be requested from fzampieri@hcor.com.br.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    10 views1 page

    Joi210083supp5 Prod 1630095299.72589

    Uploaded by

    Jonas
    Anonymized data from a study comparing intravenous fluid treatment with a balanced solution versus 0.9% saline on mortality in critically ill patients will be available beginning January 31, 2022 upon reasonable request. The request must include a short study protocol and be evaluated by the steering committee, with additional approval required from Brazilian regulatory agencies. Supporting documents such as statistical code and consent forms can also be requested from fzampieri@hcor.com.br.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    Data Sharing Statement

    Zampieri. Effect of Intravenous Fluid Treatment With a Balanced


    Solution vs 0.9% Saline on Mortality in Critically Ill Patients. JAMA.
    Published August 10, 2021. doi:10.1001/jama.2021.11684

    Data
    Data available: Yes
    Data types: Deidentified participant data, Other (please specify)
    Additional Information: Anonymized data is available upon
    reasonable request including a short study protocol. The steering
    committee will evaluate all requests. Please note that Brazilian
    regulatory agencies approval is also required.
    How to access data: Anonymized data is available upon reasonable
    request including a short study protocol. The steering committee will
    evaluate all requests. Please note that Brazilian regulatory agencies
    approval is also required.
    When available: beginning date: 01-31-2022

    Supporting Documents
    Document types: Statistical/analytic code, Informed consent form
    How to access documents: Request to fzampieri@hcor.com.br
    When available: With publication

    Additional Information
    Who can access the data: Anonymized data is available upon
    reasonable request including a short study protocol. The steering
    committee will evaluate all requests. Please note that Brazilian
    regulatory agencies approval is also required.
    T ypes of analyses: Anonymized data is available upon reasonable
    request including a short study protocol. The steering committee will
    evaluate all requests. Please note that Brazilian regulatory agencies
    approval is also required.
    Mechanisms of data availability: Anonymized data is available upon
    reasonable request including a short study protocol. The steering
    committee will evaluate all requests. Please note that Brazilian
    regulatory agencies approval is also required.

    You might also like